So-Young International Inc.

NASDAQ:SY

Medical - Healthcare Information Services

Healthcare
$1.83 -5.83%

-$0.09 today

Market cap
$239.36M
Beta
1.98
P/E (TTM)
-5.0
EPS (TTM)
-$1.95
52W Low $1.00High $6.28

Volume 0.46M

Average 0.63M

SY Financing Cash Flow

Net cash exchanged with lenders and shareholders through borrowing, repayments, buybacks, and dividends.

So-Young International Inc.NASDAQ: SY

Financing Cash Flow · Q4 FY2025 · quarter ended Dec 2025

Financing cash flow turns negative

Q4 FY2025 financing cash flow was -CN¥63.7M, compared with CN¥0 a year earlier. Trailing-twelve-month financing cash flow was -CN¥63.7M. Over 3 fiscal years it compounded at +67.4% a year.

Context

  • Financing cash flow amounted to 4.3% of revenue in FY2025, up 2.8 pp from a year earlier.
  • Financing cash flow grew in size in 2 of the last 3 fiscal years.

What to watch

Whether quarterly financing cash flow holds near -CN¥63.7M or moves back toward the trailing-twelve-month quarterly average of -CN¥15.93M.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterDec 2025
-CN¥63.7M— QoQ
Last fiscal yearDec 2025
-CN¥63.7M+196.1% YoY
LTMDec 2025
-CN¥63.7M— YoY
Financing Cash Flow past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year+196.1%——
3-year CAGR+67.4%——
5-year CAGR——
10-year CAGR——

Financing Cash Flow history

CNY · from the cash flow

Latest · FY2025
(63.7M) CNY
Year-over-year change
-196.1%

Financing Cash Flow vs competitors

How SY compares with its peers on the latest reported figures

  • Peers report in different currencies, so financing cash flow is compared through growth and share of revenue rather than absolute size.
  • Financing cash flow amounts to 4.2% of revenue for SY, versus a peer median of 57.9%.
SY Competitors
Financing Cash Flow for SY and competitors
Company Period LTM YoY 3-year CAGR% of revenue
SNDASonida Senior Living, Inc.LTM Mar 2026$1.07B USD+433.7%—259.6%
VREXVarex Imaging CorporationLTM Apr 2026$231M USD-286.4%+47.2%26.9%
ADCTADC Therapeutics S.A.LTM Mar 2026$151.21M USD+55.9%—191.0%
NMRANeumora Therapeutics, Inc. Common StockLTM Mar 2026$87.96M USD+345.2%-12.7%—
SYSo-Young International Inc.LTM Dec 2025CN¥63.7M CNY—+67.4%4.2%
OMEROmeros CorporationLTM Mar 2026$62.31M USD+66.7%—629.9%
SOPHSOPHiA GENETICS S.A.LTM Mar 2026$46.34M USD+308.7%—57.1%
LXRXLexicon Pharmaceuticals, Inc.LTM Mar 2026$40.83M USD+2642.3%—58.6%
CGEMCullinan Therapeutics, Inc.LTM Mar 2026$1.47M USD-99.4%——
SLPSimulations Plus, Inc.LTM Feb 2026$590K USD+110.3%-46.8%0.7%
LABStandard BioTools Inc.LTM Mar 2026$576K USD+100.7%-86.5%0.7%
Peer median (excluding SY) —+105.5%-29.7%57.9%

Competitors are the stored peer set for SY. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

CNY
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(37.64M)(66.11M)25.94M(587.18M)(246.91M)
Depreciation & Amortization30.08M47.09M46.09M45.92M57.21M
Deferred Income Tax1.65M(24.8M)(33.52M)(16.17M)(1.79M)
Stock-Based Compensation106.15M43.34M36.32M32.66M8.92M
Change in Working Capital(164.54M)(195M)(122.45M)(167.85M)(26.11M)
Accounts Receivables14.58M13.56M(28.95M)(61.48M)29.72M
Inventory7.87M(27.99M)(2.12M)(36.75M)(115.98M)
Accounts Payables(158.37M)0000
Other Working Capital(28.61M)(180.58M)(91.37M)(69.62M)60.14M
Other Non-Cash Items148.58M82.62M70.11M666.99M103.29M
Operating Cash Flow84.29M(112.87M)22.5M(25.63M)(105.39M)
Capital Expenditures(45.06M)(15.71M)(51.18M)(62.55M)(196.62M)
Acquisitions (Net)(636.87M)(97.49M)000
Purchases of Investments(2.02B)(1.21B)(2.27B)(1.22B)(872.29M)
Sales of Investments3.05B764.79M2.1B1.53B1.03B
Other Investing Activities(8.37M)(18.03M)17.16M10.85M500K
Investing Cash Flow339.82M(572.21M)(202.61M)257.04M(42.81M)
Debt Repayment0029.83M40M(30M)
Common Stock Issued000079K
Common Stock Repurchased(217.71M)(15.12M)(125.62M)(18.24M)(15.25M)
Dividends Paid000(43.57M)(19.03M)
Other Financing Activities969K1.54M(4.22M)298K500K
Financing Cash Flow(216.74M)(13.59M)(100.02M)(21.51M)(63.7M)
Effect of Forex Changes(9.24M)55.86M11.87M3.34M(1.48M)
Net Change in Cash198.12M(642.81M)(268.26M)213.23M(213.38M)
Free Cash Flow39.23M(128.58M)(28.68M)(88.18M)(302.01M)

So-Young International Inc.

NASDAQ:SY

Intrinsic Alpha fair value

Locked

Current Price

$1.83

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.